Boehringer Ingelheim has laid the foundation stone for its European Veterinary Research Center in Hanover.
Boehringer Ingelheim’s market leading Animal Health medication Metacam® (active ingredient: Meloxicam) obtained EU wide marketing authorisation as an oral suspension in a concentration of 15 mg/ml for use in pigs.
Boehringer Ingelheim’s Metacam® (active ingredient: Meloxicam) 5mg/ml solution for injection obtained EU wide marketing authorization for its use as an analgesic to relieve post operative pain associated with castration in piglets.
Boehringer Ingelheim Vetmedica, Inc., (BIVI) announces Drs. Keith Bretey, Erin Johnson, Jeff Okones and Brian Payne, all professional service veterinarians for the company’s swine division, completed the Executive Veterinary Program (EVP) for Swine Health and Production program at the University of Illinois.
Boehringer Ingelheim funds three research projects against swine disease PRRS with a total of €75,000
Applications to submit research proposals can be made on www.prrs.com (link is external).
CHINA - Ingelvac CircoFLEX from Boehringer Ingelheim Vetmedica is the first vaccine to be approved in China against Porcine Circovirus Disease (PCVD). Boehringer Ingelheim Vedmedica GmbH has been granted market authorisation for a vaccine for the control of Porcine Circovirus Disease (PCVD) by the Chinese regulatory authorities.
GERMANY - Prof. Hans Nauwynck, Prof. Joaquim Segalés, Danja Wiederkehr together and Dr. Xaver Sidler are the first ever winners of the European PCV2 Research Award
Get the latest news on Swine Health Subscribe to our newsletter